Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues.

PURPOSE: Significant controversy exists regarding the expression patterns of estrogen receptor beta (ERβ) in normal and diseased breast tissue. To address this issue, we have validated two ERβ antibodies, have optimized the IHC protocols for both antibodies and now report the expression patterns of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res Treat
Autors principals: Hawse, John R., Carter, Jodi M., Aspros, Kirsten G. M., Bruinsma, Elizabeth S., Koepplin, Justin W., Negron, Vivian, Subramaniam, Malayannan, Ingle, James N., Rech, Karen L., Goetz, Matthew P.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989344/
https://ncbi.nlm.nih.gov/pubmed/31571071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05441-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars